Clinically, GLP-1-based therapies offer the additional advantage of established cardiovascular protection and renal benefits, making them particularly attractive for the large proportion of MASLD patients with comorbid cardiovascular disease or type 2 diabetes
Until we have larger, more definitive studies, the safest approach is still to stop GLP-1 medications before trying to conceive. The findings, however, are exactly the kind of data we need to justify properly designed prospective trials, says Lora Shahine, MD, a reproductive endocrinologist and obstetrician-gynecologist at PNWF IVY Fertility Center in Bellevue, Washington, and host of the Brave and Curious podcast
(II),
PlexusDx monitors your progress monthly and may recommend the Precision Peptide Genetic Test if your results plateau, allowing for protocol refinement based on your unique genetic response profile
There is early research looking at a possible link between GLP-1 medicines and certain rare problems that affect the optic nerve